Advertisement
Screener

CHEMED CORPORATION (CHE) Overview

CHEMED CORPORATION (CHE) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 5.13; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 4.84; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 4.46; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 3.57; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$350.16$387.70$429.27$475.30$526.26$582.692025-11-062026-11-06$350.16$400.84$458.85$525.26$601.28$688.302021-11-082026-11-06$130.38$182.56$255.64$357.96$501.23$701.852016-11-072026-11-06$30.44$57.96$110.36$210.13$400.11$761.852006-11-062026-11-06$1.42$5.87$24.22$99.83$411.53$1,696.501973-05-032026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$528.09
Previous close
$512.05
Change
$16.04
Change (%)
3.13%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

CHE
+20.15%
S&P 500
(m)

1 year

CHE
+13.86%
S&P 500
(m)

3 years

CHE
-0.25%
S&P 500
(m)

5 years

CHE
+11.13%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 5.13

3.493.944.404.855.3131 Mar 2025: estimate (m); actual 4.8631 Mar 2025(m)30 Jun 2025: estimate (m); actual 3.5730 Jun 2025(m)30 Sept 2025: estimate (m); actual 4.4630 Sept 2025(m)31 Mar 2026: estimate (m); actual 4.8431 Mar 2026(m)30 Jun 2026: estimate (m); actual 5.1330 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)5.13(m)(m)
1 Jan 202631 Mar 2026(m)4.84(m)(m)
1 Jul 202530 Sept 2025(m)4.46(m)(m)
1 Apr 202530 Jun 2025(m)3.57(m)(m)
1 Jan 202531 Mar 2025(m)4.86(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 18.34

16.4517.3618.2619.1620.0731 Dec 2021: estimate (m); actual 16.8531 Dec 2021(m)31 Dec 2022: estimate (m); actual 16.5331 Dec 2022(m)31 Dec 2023: estimate (m); actual 17.9331 Dec 2023(m)31 Dec 2024: estimate (m); actual 19.8931 Dec 2024(m)31 Dec 2025: estimate (m); actual 18.3431 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)18.34(m)(m)
1 Jan 202431 Dec 2024(m)19.89(m)(m)
1 Jan 202331 Dec 2023(m)17.93(m)(m)
1 Jan 202231 Dec 2022(m)16.53(m)(m)
1 Jan 202131 Dec 2021(m)16.85(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 673.25M ■ Earnings 67.70M — Profit margin 10.06%

-291.60M-30.4%64.48M-16.5%420.55M-2.6%776.63M11.3%30 Sept 2025: revenue 624.90M; earnings 64.24M; profit margin 10.28%30 Sept 202531 Dec 2025: revenue 639.34M*; earnings -188.22M*; profit margin -29.44%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 657.51M; earnings 66.30M; profit margin 10.08%31 Mar 202630 Jun 2026: revenue 673.25M; earnings 67.70M; profit margin 10.06%30 Jun 2026

31 Dec 2025 ■ Revenue 2.53B ■ Earnings 0.00B — Profit margin 0.01%

-0.30B-1.0%0.74B-0.3%1.79B0.4%2.83B1.0%31 Dec 2022: revenue 1.20B; earnings 0.00B; profit margin 0.02%31 Dec 202231 Dec 2023: revenue 1.32B; earnings 0.00B; profit margin 0.02%31 Dec 202331 Dec 2024: revenue 1.53B; earnings 0.00B; profit margin 0.02%31 Dec 202431 Dec 2025: revenue 2.53B; earnings 0.00B; profit margin 0.01%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$528.09(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$528.09High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning CHE

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$10.02M
Profit margin
0.39%
Return on assets · 12 month
0.61%
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
152.75K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
3.11%*
Total return · month
-2.16%*
Total return · quarter
11.49%*
Total return · half year
39.29%*
Total return · year to date
20.15%*
Total return · 1 year
13.86%*
Total return · 3 years
-0.25%*
Total return · 5 years
11.13%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$2.60B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

CHEMED CORPORATION Overview

View more →

(m)

(m)

SEC CIK
19584
Industry (SIC)
8082 Services-Home Health Care Services
Country of operation
United States
Business address
SUITE 2600, 255 E FIFTH ST, CINCINNATI, Ohio, 45202, United States
Fiscal year end
1231
Phone
(513)762-6690

Similar stocks

Stock NameCountryMarket CapPE Ratio
Option Care Health, Inc. (OPCH)United States$3.602B20.52
Aveanna Healthcare Holdings, Inc. (AVAH)United States$2.703B7.22
Addus HomeCare Corp (ADUS)United States$2.129B17.80
BrightSpring Health Services, Inc. (BTSG)United States$11.078B37.65
AdaptHealth Corp. (AHCO)United States$0.759B-6.22